semaglutide and tirzepatide. Tirzepatide vs Semaglutide + Tirzepatide Combination: Clinical

It involves changes in your relationship with food, shifts in social dynamics around meals, and often significant psychological adjustments as your body transforms

To achieve the best long-term results, strength training plays a critical role -especially for patients enrolled in GLP-1 weight loss Chicago programs

Here is what 48 weeks of treatment produced: ### Weight Loss by Dose - **1mg weekly:** ~8% body weight loss (initiation dose, sub-therapeutic) - **4mg weekly:** ~17% loss -- comparable to maximum-dose semaglutide - **8mg weekly:** ~22% loss -- comparable to maximum-dose tirzepatide - **12mg weekly:** ~24.2% loss -- the highest ever recorded in any obesity drug trial ### What 24% Loss Looks Like in Practice | Starting Weight | 24% Loss | New Weight | |----------------|----------|------------| | 200 lbs | 48 lbs | 152 lbs | | 250 lbs | 60 lbs | 190 lbs | | 300 lbs | 72 lbs | 228 lbs | | 350 lbs | 84 lbs | 266 lbs | Perhaps most striking: over 50% of participants on the 12mg dose lost 25% or more of their body weight, and the weight loss trajectory was still declining at week 48

The homeostatic system preserves energy balance by enhancing the drive to eat when energy stores are depleted, whereas hedonic feeding is motivated by the rewarding and pleasurable properties of food

Liver and cardiovascular markers: Cagrilintide is also studied for impacts on liver fat, cardiovascular risk markers, and systemic metabolic signaling, including lipid profiles

doi: 10.12182/20230160201, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 81